The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Mitochondrial complex I activity and NAD+/NADH balance regulate breast cancer progression
Open accessAbstract
Despite advances in clinical therapy, metastasis remains the leading cause of death in breast cancer patients. Mutations in mitochondrial DNA, including those affecting complex I and oxidative phosphorylation, are found in breast tumors and could facilitate metastasis. This study identifies mitochondrial complex I as critical for defining an aggressive phenotype in breast cancer cells. Specific enhancement of mitochondrial complex I activity inhibited tumor growth and metastasis through regulation of the tumor cell NAD+/NADH redox balance, mTORC1 activity, and autophagy. Conversely, nonlethal reduction of NAD+ levels by interfering with nicotinamide phosphoribosyltransferase expression rendered tumor cells more aggressive and increased metastasis. The results translate into a new therapeutic strategy: enhancement of the NAD+/NADH balance through treatment with NAD+ precursors inhibited metastasis in xenograft models, increased animal survival, and strongly interfered with oncogene-driven breast cancer progression in the MMTV-PyMT mouse model. Thus, aberration in mitochondrial complex I NADH dehydrogenase activity can profoundly enhance the aggressiveness of human breast cancer cells, while therapeutic normalization of the NAD+/NADH balance can inhibit metastasis and prevent disease progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
mTOR: from growth signal integration to cancer, diabetes and ageing
Zoncu, R., Efeyan, A., & Sabatini, D. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3025 · Cited by 3,941
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes
Klionsky, D. J., Abeliovich, H., Agostinis, P., Agrawal, D. K., Aliev, G., Askew, D. S., Baba, M., Baehrecke, E. H., Bahr, B. A., Ballabio, A., et al. (2008) · Autophagy · doi:10.4161/auto.5338 · Cited by 2,230
Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy
Lin, E. Y., Nguyen, A. V., Russell, R. G., & Pollard, J. W. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.6.727 · Cited by 1,594
ROS-Generating Mitochondrial DNA Mutations Can Regulate Tumor Cell Metastasis
Ishikawa, K., Takenaga, K., Akimoto, M., Koshikawa, N., Yamaguchi, A., Imanishi, H., Nakada, K., Honma, Y., & Hayashi, J.-I. (2008) · Science · doi:10.1126/science.1156906 · Cited by 1,444
Reactive oxygen species in cancer cells: Live by the sword, die by the sword
Schumacker, P. T. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.015 · Cited by 1,242
Kume, S., Uzu, T., Horiike, K., Chin-Kanasaki, M., Isshiki, K., Araki, S.-I., Sugimoto, T., Haneda, M., Kashiwagi, A., & Koya, D. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41376 · Cited by 640
SIRT1 Negatively Regulates the Mammalian Target of Rapamycin
Ghosh, H. S., McBurney, M., & Robbins, P. D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009199 · Cited by 397
MDA-MB-435 and M14 Cell Lines: Identical but not M14 Melanoma?
Chambers, A. F. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1528 · Cited by 218
Research works printed but not linked: 54
- 10.1200/JCO.2008.19.9844 · DOI · Paper page
- 10.1172/JCI60534 · DOI · Paper page
- Warburg, 1956, Science., 124, 269, 10.1126/science.124.3215.269 · DOI · Paper page
- Schwartz, 1974, J Biol Chem., 249, 4138, 10.1016/S0021-9258(19)42494-0 · DOI
- 10.1038/sj.onc.1209607 · DOI · Paper page
- 10.1146/annurev.genet.39.110304.095751 · DOI · Paper page
- 10.1158/1535-7163.MCT-08-1170 · DOI · Paper page
- Ma, 2010, Biochim Biophys Acta., 1797, 29, 10.1016/j.bbabio.2009.07.008 · DOI
- 10.1007/s00432-010-0912-x · DOI
- 10.1186/1476-4598-1-9 · DOI
- Parrella, 2001, Cancer Res., 61, 7623
- 10.1158/1078-0432.CCR-07-4131 · DOI · Paper page
- 10.1007/s10549-010-1092-8 · DOI
- 10.1111/j.1432-1033.1992.tb16587.x · DOI
- 10.1073/pnas.95.16.9167 · DOI · Paper page
- 10.1074/jbc.M007033200 · DOI
- 10.1371/journal.pone.0025910 · DOI
- 10.1089/rej.2009.0854 · DOI
- 10.1371/journal.pone.0011472 · DOI
- 10.1371/journal.pone.0016288 · DOI
- 10.1073/pnas.0911539107 · DOI
- 10.1093/hmg/ddr395 · DOI
- 10.1016/j.ymgme.2011.11.188 · DOI
- 10.1016/j.cell.2009.03.048 · DOI · Paper page
- 10.1016/j.gde.2010.12.008 · DOI · Paper page
- 10.1016/j.ceb.2009.10.008 · DOI · Paper page
- 10.1126/science.290.5497.1717 · DOI · Paper page
- 10.1016/j.febslet.2011.03.045 · DOI
- 10.1016/j.mad.2010.03.006 · DOI
- Hasmann, 2003, Cancer Res., 63, 7436
- Brinkley, 1980, Cancer Res., 40, 3118
- 10.1038/nrendo.2011.225 · DOI · Paper page
- 10.1074/jbc.M112.363747 · DOI · Paper page
- Guy, 1992, Mol Cell Biol., 12, 954, 10.1128/MCB.12.3.954 · DOI · Paper page
- 10.1016/j.febslet.2010.07.048 · DOI
- 10.1002/jcp.22980 · DOI
- 10.2741/e247 · DOI
- Baracca, 2010, Biochim Biophys Acta., 1797, 314, 10.1016/j.bbabio.2009.11.006 · DOI
- 10.1038/cr.2011.145 · DOI · Paper page
- Tu, 2011, Biochim Biophys Acta., 1807, 1125, 10.1016/j.bbabio.2011.04.015 · DOI
- 10.1038/onc.2010.468 · DOI · Paper page
- 10.1002/emmm.201201250 · DOI · Paper page
- Kirkland, 2012, Mutat Res., 733, 14, 10.1016/j.mrfmmm.2011.11.008 · DOI
- 10.1083/jcb.200512100 · DOI · Paper page
- 10.1074/jbc.M109.077271 · DOI · Paper page
- 10.1074/jbc.M805711200 · DOI · Paper page
- 10.1073/pnas.0712145105 · DOI · Paper page
- 10.1111/j.1474-9726.2010.00548.x · DOI · Paper page
- 10.1073/pnas.0603269103 · DOI · Paper page
- 10.1038/onc.2010.406 · DOI
- 10.1038/nsmb.1941 · DOI
- 10.1038/nrc2013 · DOI · Paper page
- 10.1158/0008-5472.CAN-06-3137 · DOI · Paper page
- Trounce, 1996, Methods Enzymol., 264, 484, 10.1016/S0076-6879(96)64044-0 · DOI · Paper page
Cited by
Birsoy, K., Wang, T., Chen, W. W., Freinkman, E., Abu-Remaileh, M., & Sabatini, D. M. (2015) · Cell · doi:10.1016/j.cell.2015.07.016 · Cited by 1,388
NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential
Xie, N., Zhang, L., Gao, W., Huang, C., Huber, P. E., Zhou, X., Li, C., Shen, G., & Zou, B. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00311-7 · Cited by 1,052
Lactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches
de la Cruz-López, K. G., Castro-Muñoz, L. J., Reyes-Hernández, D. O., García-Carrancá, A., & Manzo-Merino, J. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01143 · Cited by 940
“Currently it is known that, certain cancer cells may also actively use OXPHOS or a combination of OXPHOS and glycolysis for ATP production (45, 46).”
BackgroundTumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism
Zhao, H., Yang, L., Baddour, J., Achreja, A., Bernard, V., Moss, T., Marini, J. C., Tudawe, T., Seviour, E. G., San Lucas, F. A., et al. (2016) · eLife · doi:10.7554/elife.10250 · Cited by 927
Glutaminolysis: A Hallmark of Cancer Metabolism
Yang, L., Venneti, S., & Nagrath, D. (2017) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071516-044546 · Cited by 859
Metadata
- Authors
- Santidrian, A. F., Matsuno-Yagi, A., Ritland, M., Seo, B. B., LeBoeuf, S. E., Gay, L. J., Yagi, T., & Felding-Habermann, B.
- Venue
- Journal of Clinical Investigation
- Published
- 2013-02-15
- Volume
- 123
- Issue
- 3
- Pages
- 1068-1081
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2124276356
- Cited by
- 433
- References
- 9
- FWCI
- 11.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mitochondrial complex I activity and NAD+/NADH balance regulate breast cancer progression. https://app.cochat.ai/papers/10.1172/jci64264
- The paper
- Santidrian, A. F., Matsuno-Yagi, A., Ritland, M., Seo, B. B., LeBoeuf, S. E., Gay, L. J., Yagi, T., & Felding-Habermann, B. (2013). Mitochondrial complex I activity and NAD+/NADH balance regulate breast cancer progression. Journal of Clinical Investigation. https://doi.org/10.1172/jci64264
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
